Literature DB >> 9053554

DNA diagnosis of X-linked adrenoleukodystrophy.

S Seneca1, W Lissens.   

Abstract

The X-linked adrenoleukodystrophy (ALD) gene was identified recently and is predicted to encode a 745-amino-acid peroxisomal membrane protein. Strategies have been designed for the search for mutations in the ALD gene in patients. Several mutations have now been found and it seems that many different mutations are responsible for ALD. There is no straightforward correlation between genotype and phenotype since the same mutation can cause different ALD phenotypes in the same family. However, once a mutation has been found in a family, it can be traced in all at-risk individuals of that family, both post- and prenatally, without the need for very long-chain fatty acid (VLCFA) analysis. Segregation analysis with extragenic and intragenic polymorphisms may remain useful in families where mutation analysis is not possible for practical reasons; VLCFA analysis and measurement of the peroxisomal beta-oxidation with C26:0 fatty acid as a substrate will remain the alternative. We also briefly discuss the possibilities of DNA diagnosis for other peroxisomal disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9053554     DOI: 10.1007/bf00711427

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  60 in total

Review 1.  PCR-SSCP: a method for detection of mutations.

Authors:  K Hayashi
Journal:  Genet Anal Tech Appl       Date:  1992-06

2.  Gonadal mosaicism in a family with adrenoleukodystrophy: molecular diagnosis of carrier status among daughters of a gonadal mosaic when direct detection of the mutation is not possible.

Authors:  G E Graham; P M MacLeod; D P Lillicrap; P J Bridge
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Newborn screening by DNA analysis of dried blood spots.

Authors:  E M Rubin; K A Andrews; Y W Kan
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

4.  Molecular genetics of inherited variation in human color vision.

Authors:  J Nathans; T P Piantanida; R L Eddy; T B Shows; D S Hogness
Journal:  Science       Date:  1986-04-11       Impact factor: 47.728

5.  Prenatal diagnosis of Zellweger syndrome using DNA analysis.

Authors:  N Shimozawa; Y Suzuki; T Orii; T Tsukamoto; Y Fujiki
Journal:  Prenat Diagn       Date:  1993-02       Impact factor: 3.050

6.  Human peroxisomal L-alanine: glyoxylate aminotransferase. Evolutionary loss of a mitochondrial targeting signal by point mutation of the initiation codon.

Authors:  Y Takada; N Kaneko; H Esumi; P E Purdue; C J Danpure
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

7.  Linkage of adrenoleukodystrophy to a polymorphic DNA probe.

Authors:  P R Aubourg; G H Sack; D A Meyers; J J Lease; H W Moser
Journal:  Ann Neurol       Date:  1987-04       Impact factor: 10.422

8.  Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome.

Authors:  J Gärtner; H Moser; D Valle
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

Review 9.  Adrenoleukodystrophy and other peroxisomal diseases.

Authors:  P Aubourg
Journal:  Curr Opin Genet Dev       Date:  1994-06       Impact factor: 5.578

10.  Adrenoleukodystrophy: a complex chromosomal rearrangement in the Xq28 red/green-color-pigment gene region indicates two possible gene localizations.

Authors:  R Feil; P Aubourg; J Mosser; A M Douar; D Le Paslier; C Philippe; J L Mandel
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

View more
  2 in total

1.  X-linked adrenoleukodystrophy: improved prenatal diagnosis using both biochemical and immunological methods.

Authors:  R J Wanders; P W Mooyer; C Dekker; P Vreken
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 2.  Clinical approach to inherited peroxisomal disorders.

Authors:  F Poggi-Travert; B Fournier; B T Poll-The; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.